6.
Davies J, Lewis M, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs P
. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol. 2011; 155(3):308-17.
DOI: 10.1111/j.1365-2141.2011.08843.x.
View
7.
Bezwada H, Nazarian D, Booth Jr R
. Haemophilus influenza infection complicating a total knee arthroplasty. Clin Orthop Relat Res. 2002; (402):202-5.
DOI: 10.1097/00003086-200209000-00019.
View
8.
Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J
. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol. 2004; 42(2):524-9.
PMC: 344522.
DOI: 10.1128/JCM.42.2.524-529.2004.
View
9.
Wadhwa P, Morrison V
. Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006; 33(2):240-9.
DOI: 10.1053/j.seminoncol.2005.12.013.
View
10.
ONeill J, St Geme 3rd J, Cutter D, Adderson E, Anyanwu J, Jacobs R
. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol. 2003; 41(7):3064-9.
PMC: 165342.
DOI: 10.1128/JCM.41.7.3064-3069.2003.
View
11.
Campos J, Roman F, Perez-Vazquez M, Oteo J, Aracil B, Cercenado E
. Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features. Clin Infect Dis. 2003; 37(6):841-5.
DOI: 10.1086/377232.
View
12.
Croxtall J, Keating G
. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs. 2009; 11(5):349-57.
DOI: 10.2165/11202760-000000000-00000.
View
13.
Ladhani S, Ramsay M, Chandra M, Slack M
. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis. 2008; 8(5):275-6.
DOI: 10.1016/S1473-3099(08)70078-1.
View
14.
Ladhani S, Slack M, Heath P, von Gottberg A, Chandra M, Ramsay M
. Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infect Dis. 2010; 16(3):455-63.
PMC: 3322004.
DOI: 10.3201/eid1603.090290.
View
15.
Peltola H
. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2001; 13(2):302-17.
PMC: 100154.
DOI: 10.1128/CMR.13.2.302.
View
16.
Pittman M
. VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE. J Exp Med. 2009; 53(4):471-92.
PMC: 2131978.
DOI: 10.1084/jem.53.4.471.
View